Purchase Order 75N91018P00711

<p>The National Cancer Institute awarded a purchase order to New England Biolabs, Inc. for $10,680.00 on August 1, 2018. Performance is in Bethesda, Maryland. The order covers molecular biology products, reagents, and kits for life sciences research. The contract is firm fixed price with an ultimate completion date of September 1, 2018.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $12,768.84 on September 11, 2018, with completion scheduled for September 18, 2019. Pricing is fixed-price with economic price adjustment. Place of performance is Bethesda, Maryland. The source does not identify the specific items or services procured under this order.</p>

<p>The National Human Genome Research Institute awarded a purchase order to New England Biolabs, Inc. for $10,494.90 on July 28, 2017. Performance occurs in North Bethesda, Maryland, with an ultimate completion date of August 27, 2017. The order is firm-fixed-price with no set-aside designation. The source does not specify the particular molecular biology products, reagents, or other supplies procured under this purchase order.</p>

<p>The National Cancer Institute awarded a purchase order to Nexome Genomics Inc. for $10,000.00 on July 2, 2018. Performance occurs in Bethesda, Maryland. The order is firm fixed price with no small business set-aside. Work is scheduled for completion by August 2, 2018.</p>

<p>The National Cancer Institute issued a purchase order to Nexome Genomics Inc. for $12,250 on August 7, 2018. Work is performed in Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of September 7, 2018. No small business set-aside applies.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for biologicals valued at $13,401.67 on March 12, 2020, with an ultimate completion date of April 9, 2020. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. valued at $21,581.00 on August 28, 2018, with completion scheduled for September 28, 2018. Performance occurs at Bethesda, Maryland. The order is firm fixed price with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to Eppendorf North America, Inc. for $12,841.60 on September 22, 2020, with completion on December 22, 2020. The order covers laboratory equipment on a firm fixed-price basis. Place of performance is Bethesda, Maryland.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $24,158.08 on October 19, 2017, with an ultimate completion date of November 19, 2018. Performance occurs at Bethesda, Maryland. The order is firm fixed price with no set-aside designation. Specific requirements are not detailed in the source material.</p>

<p>The National Cancer Institute awarded a purchase order to Nexome Genomics Inc. for $14,575.00 on July 2, 2018. Performance is based in Bethesda, Maryland. The order carries a firm fixed price structure and a completion date of August 2, 2018. No set-aside category applies.</p>